Literature DB >> 34764204

Myeloid Cell-Derived Oxidized Lipids and Regulation of the Tumor Microenvironment.

Kristin C Hicks1, Yulia Y Tyurina2,3,4, Valerian E Kagan2,3,4, Dmitry I Gabrilovich5.   

Abstract

Immunosuppressive myeloid cells play a major role in cancer by negatively regulating immune responses, promoting tumor progression, and limiting the efficacy of cancer immunotherapy. Immunosuppression is mediated by various mechanisms dependent upon the type of myeloid cell involved. In recent years, a more universal mechanism of immunosuppressive activity of myeloid cells has emerged: Generation of oxidized lipids. Oxidized lipids accumulate in all types of myeloid cells and are often transferred between cells. In this review, we discuss mechanisms involved in the generation and biological role of myeloid cell-derived oxidized lipids in cancer. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34764204      PMCID: PMC8770601          DOI: 10.1158/0008-5472.CAN-21-3054

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  89 in total

1.  Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways.

Authors:  Gabriela Bomfim Ferreira; An-Sofie Vanherwegen; Guy Eelen; Ana Carolina Fierro Gutiérrez; Leentje Van Lommel; Kathleen Marchal; Lieve Verlinden; Annemieke Verstuyf; Tatiane Nogueira; Maria Georgiadou; Frans Schuit; Décio L Eizirik; Conny Gysemans; Peter Carmeliet; Lut Overbergh; Chantal Mathieu
Journal:  Cell Rep       Date:  2015-02-07       Impact factor: 9.423

2.  Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.

Authors:  Adeleye Oluwatosin Adeshakin; Wan Liu; Funmilayo O Adeshakin; Lukman O Afolabi; Mengqi Zhang; Guizhong Zhang; Lulu Wang; Zhihuan Li; Lilong Lin; Qin Cao; Dehong Yan; Xiaochun Wan
Journal:  Cell Immunol       Date:  2021-01-19       Impact factor: 4.868

Review 3.  Dendritic Cells and Cancer Immunity.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

4.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.

Authors:  Andrea Viale; Piergiorgio Pettazzoni; Costas A Lyssiotis; Haoqiang Ying; Nora Sánchez; Matteo Marchesini; Alessandro Carugo; Tessa Green; Sahil Seth; Virginia Giuliani; Maria Kost-Alimova; Florian Muller; Simona Colla; Luigi Nezi; Giannicola Genovese; Angela K Deem; Avnish Kapoor; Wantong Yao; Emanuela Brunetto; Ya'an Kang; Min Yuan; John M Asara; Y Alan Wang; Timothy P Heffernan; Alec C Kimmelman; Huamin Wang; Jason B Fleming; Lewis C Cantley; Ronald A DePinho; Giulio F Draetta
Journal:  Nature       Date:  2014-08-10       Impact factor: 49.962

Review 5.  Redox (phospho)lipidomics of signaling in inflammation and programmed cell death.

Authors:  Yulia Y Tyurina; Claudette M St Croix; Simon C Watkins; Alan M Watson; Michael W Epperly; Tamil S Anthonymuthu; Elena R Kisin; Irina I Vlasova; Olga Krysko; Dmitri V Krysko; Alexandr A Kapralov; Haider H Dar; Vladimir A Tyurin; Andrew A Amoscato; Elena N Popova; Sergey B Bolevich; Peter S Timashev; John A Kellum; Sally E Wenzel; Rama K Mallampalli; Joel S Greenberger; Hulya Bayir; Anna A Shvedova; Valerian E Kagan
Journal:  J Leukoc Biol       Date:  2019-05-09       Impact factor: 4.962

6.  Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.

Authors:  Fokhrul Hossain; Amir A Al-Khami; Dorota Wyczechowska; Claudia Hernandez; Liqin Zheng; Krzystoff Reiss; Luis Del Valle; Jimena Trillo-Tinoco; Tomasz Maj; Weiping Zou; Paulo C Rodriguez; Augusto C Ochoa
Journal:  Cancer Immunol Res       Date:  2015-05-29       Impact factor: 11.151

7.  Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation.

Authors:  Urban Svajger; Natasa Obermajer; Matjaz Jeras
Journal:  Immunology       Date:  2009-11-25       Impact factor: 7.397

8.  Fatty acid transport protein 2 reprograms neutrophils in cancer.

Authors:  Filippo Veglia; Vladimir A Tyurin; Maria Blasi; Alessandra De Leo; Andrew V Kossenkov; Laxminarasimha Donthireddy; Tsun Ki Jerrick To; Zach Schug; Subhasree Basu; Fang Wang; Emanuela Ricciotti; Concetta DiRusso; Maureen E Murphy; Robert H Vonderheide; Paul M Lieberman; Charles Mulligan; Brian Nam; Neil Hockstein; Gregory Masters; Michael Guarino; Cindy Lin; Yulia Nefedova; Paul Black; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  Nature       Date:  2019-04-17       Impact factor: 49.962

Review 9.  Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them.

Authors:  M A F Yahaya; M A M Lila; S Ismail; M Zainol; N A R Nik Mohd Afizan
Journal:  J Immunol Res       Date:  2019-02-25       Impact factor: 4.818

Review 10.  Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy.

Authors:  Xin Peng; Youe He; Jun Huang; Yongguang Tao; Shuang Liu
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

View more
  2 in total

1.  PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen.

Authors:  Mingyu Liu; Chong Wu; Shufeng Luo; Qiaomin Hua; Hai-Tian Chen; Yulan Weng; Junyu Xu; Huiling Lin; Lu Wang; Jinheng Li; Lan Zhu; Zhenhong Guo; Shi-Mei Zhuang; Tiebang Kang; Limin Zheng
Journal:  J Exp Med       Date:  2022-03-10       Impact factor: 17.579

2.  Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma.

Authors:  Ana Costa; Cécile Thirant; Amira Kramdi; Cécile Pierre-Eugène; Caroline Louis-Brennetot; Orphée Blanchard; Didier Surdez; Nadege Gruel; Eve Lapouble; Gaëlle Pierron; Deborah Sitbon; Hervé Brisse; Arnaud Gauthier; Paul Fréneaux; Mylène Bohec; Virginie Raynal; Sylvain Baulande; Renaud Leclere; Gabriel Champenois; Andre Nicolas; Didier Meseure; Angela Bellini; Aurelien Marabelle; Birgit Geoerger; Fatima Mechta-Grigoriou; Gudrun Schleiermacher; Laurie Menger; Olivier Delattre; Isabelle Janoueix-Lerosey
Journal:  J Immunother Cancer       Date:  2022-08       Impact factor: 12.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.